New Therapies for T-Cell Lymphomas on the Horizon

There is a critical need for new therapies for T-cell lymphomas, and with ongoing trials of mTOR and aurora kinase inhibitors, PI3K inhibitors, and others, new options may be on the horizon.

Source: CancerNetwork - February 28, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Conferences/ICHM 2017 Leukemia & Lymphoma Source Type: news